HERON THERAPEUTICS, INC. /DE/ SEC filings
Every EDGAR filing for HERON THERAPEUTICS, INC. /DE/ (HRTX), newest first, with AI summaries and stories.
- Ticker
- HRTX
- CIK
- 818033
- Sector
- Biotech and pharma
- Latest filing
- Sep 29
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE Mark Earl Hensley, insider filing for HRTX
Mark Earl Hensley, reporting
NOTABLE10-QHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 2 insider filings
Mark Earl Hensley, insider filing for HRTX
Show all 2
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Mark Earl Hensley, reporting
ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 2 insider filings
Ira Duarte, insider filing for HRTX
Show all 2
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Ira Duarte, reporting
ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 3 insider filings
Craig A Collard, insider filing for HRTX
Show all 3
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Craig A Collard, reporting
ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE Ira Duarte, insider filing for HRTX
Ira Duarte, reporting
ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE William P Forbes, insider filing for HRTX
William P Forbes, reporting
ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINESCHEDULE 13G/AHERON THERAPEUTICS, INC. /DE/HRTXLIVE Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
NOTABLE10-QHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE Mark Earl Hensley, insider filing for HRTX
Mark Earl Hensley, reporting
ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 4 insider filings
Mark Earl Hensley, insider filing for HRTX
Show all 4
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Mark Earl Hensley, reporting
ROUTINEARSHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINEDEFA14AHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINEDEF 14AHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE William P Forbes, insider filing for HRTX
William P Forbes, reporting
ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 2 insider filings
Craig A Collard, insider filing for HRTX
Show all 2
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Craig A Collard, reporting
ROUTINEPRE 14AHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE Craig A Collard, insider filing for HRTX
Craig A Collard, reporting
ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINESCHEDULE 13G/AHERON THERAPEUTICS, INC. /DE/HRTXLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
NOTABLE10-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINE8-KHERON THERAPEUTICS, INC. /DE/HRTXLIVE ROUTINESCHEDULE 13G/AHERON THERAPEUTICS, INC. /DE/HRTXLIVE Ownership stake disclosure by Clearline Capital LP (amended)
Clearline Capital LP, filed by
ROUTINE4HERON THERAPEUTICS, INC. /DE/HRTXLIVE 12 insider filings
Thomas Cusack, insider filing for HRTX
Show all 12
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
- 4Insider filing for HRTX
Thomas Cusack, reporting